Celsius is in a sustained, severe downtrend, with the stock down 54.58% over the past year and 43.98% year-to-date, a dramatic reversal from its prior growth-stock status. At the current price of $26.75, the stock sits just 13.5% above its 52-week low of $23.56 and a staggering 59.9% below its 52-week high of $66.74, placing it at roughly 7.2% of its 52-week range — a positioning that signals persistent selling pressure rather than a healthy pullback, and one that historically precedes either capitulation or a prolonged base-building phase. The maximum drawdown of -63.35% underscores the depth of the derating and the risk that momentum traders remain firmly on the short side. Recent momentum offers no relief: the stock is down 14.51% over the past month and 19.33% over three months, both sharply worse than the S&P 500's +0.59% and +3.34% respective gains, producing relative strength readings of -15.10 and -22.67. The 1-month decline is steeper than the 3-month decline, indicating momentum is decelerating further rather than stabilizing, and the August 6 earnings-related plunge from $29.15 to $23.77 on elevated volume marked a clear distribution event. With the stock failing to reclaim the $30 level since early September and printing a lower high near $35.34 in late August, the short-term trend remains firmly negative and diverges bearishly from any mean-reversion thesis. Key technical levels are well defined: support rests at the 52-week low of $23.56, and a breakdown below that level would likely trigger another leg of momentum-driven selling and open the door to new multi-year lows. Resistance is layered, with the first hurdle at the $30 psychological level, followed by the August swing high of $35.34 and the far-distant 52-week high of $66.74; reclaiming $30 would be the first credible sign of stabilization. The beta of 0.922 suggests the stock is slightly less volatile than the broader market on a statistical basis, but this understates the idiosyncratic risk — the -63.35% max drawdown and 18% single-day earnings drop show that company-specific shocks, not market beta, are the dominant risk driver, which argues for smaller position sizing and wider stops.

Revenue growth has reaccelerated on an acquisition-boosted basis but masks underlying brand weakness: Q2 2026 revenue of $817.9 million grew 10.64% year-over-year, a sharp deceleration from the prior-year quarter's $739.3 million base and a sequential step-up from Q1 2026's $782.6 million. The multi-quarter trend shows revenue climbing from $721.6 million in Q4 2025 to $782.6 million in Q1 2026 to $817.9 million in Q2 2026, but the year-over-year comparison is flattered by the Alani Nu and Rockstar acquisitions, with the flagship Celsius brand reportedly declining — a critical distinction that suggests organic growth is materially weaker than the headline 10.64% implies. With 95% of revenue concentrated in North America and a single reportable segment of $817.9 million, the company lacks geographic or segment diversification to offset a slowdown in its core brand, making the growth trajectory highly dependent on new product innovation and PepsiCo shelf-space execution. Profitability is positive but volatile and deteriorating sequentially: Q2 2026 net income was $36.4 million (net margin 4.45%) on gross margin of 48.13%, down from Q1 2026's $110.1 million net income (14.07% net margin) and 48.31% gross margin, and a steep decline from Q2 2025's $99.9 million net income (13.51% net margin) and 51.52% gross margin. The gross margin compression of roughly 340 basis points year-over-year points to rising input costs, promotional intensity, and unfavorable product mix, while the operating margin of 5.61% and EBITDA margin of 11.15% in Q2 2026 are well below the 19.34% operating margin and 21.19% EBITDA margin posted in Q2 2025 — a dramatic profitability reset that reflects both acquisition integration costs and competitive pressure. The Q3 2025 quarter, which posted a -$61.0 million net loss and -8.41% net margin, illustrates how quickly results can swing, and the trailing PE of 182.96x on EPS of $0.01 confirms that trailing earnings are essentially negligible relative to the share price. The balance sheet is a relative strength: debt-to-equity of just 0.228 and a current ratio of 1.68 indicate modest leverage and adequate liquidity, with $633.1 million in cash at the end of Q2 2026. Free cash flow tells a more nuanced story — TTM FCF of $462.8 million is healthy and Q2 2026 generated $205.5 million in FCF on $222.5 million of operating cash flow, but the prior Q4 2025 quarter saw -$130.0 million in FCF and -$119.4 million in operating cash flow due to a $205.9 million working capital drain, highlighting the volatility inherent in the co-packer model. ROE of just 3.67% and ROA of 8.85% are underwhelming for a consumer growth company, and the $95.5 million in stock repurchases during Q2 2026, alongside $14.1 million in dividends, suggests management is returning capital even as the core business faces headwinds — a signal that may be interpreted as confidence or as a lack of high-return reinvestment opportunities.